Last reviewed · How we verify
Lactobacillus gasseri BGP345A
At a glance
| Generic name | Lactobacillus gasseri BGP345A |
|---|---|
| Also known as | BGP345A |
| Sponsor | BioGaia Pharma AB |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lactobacillus gasseri BGP345A CI brief — competitive landscape report
- Lactobacillus gasseri BGP345A updates RSS · CI watch RSS
- BioGaia Pharma AB portfolio CI